405 results
Page 3 of 21
PX14A6G
i7kf 5nzgzlj7wi0j
4 May 23
Letter to shareholders
8:08am
8-K
EX-99.1
shmvuw txo55z4uh349
27 Apr 23
AbbVie Reports First-Quarter 2023 Financial Results
7:36am
8-K
vglczzjxjgp0nx
5 Apr 23
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:33pm
S-8
kjpj5mxz0gm
4 Nov 22
Registration of securities for employees
5:45pm
8-K
EX-99.1
kz0cobhvog12plbtix
28 Oct 22
AbbVie Reports Third-Quarter 2022 Financial Results
7:48am
8-K
EX-10.1
7y1day5uls69xya60cx7
14 Oct 22
Departure of Directors or Certain Officers
5:02pm
8-K
1pb4schckxn89h3
5 Oct 22
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:14pm
8-K
EX-99.1
eh7idgqc5uwe
29 Jul 22
AbbVie Reports Second-Quarter 2022 Financial Results
7:49am
8-K
i1ar me24
6 Jul 22
Guidance Including the Impact of Acquired IPR&D and Milestones Expense Incurred During the Second Quarter of 2022
4:17pm
8-K
vd5pxg1d
28 Jun 22
Departure of Directors or Certain Officers
9:16am
11-K
7ea skhc3khtlq2r9o8
23 Jun 22
Annual report of employee stock purchases
5:07pm
11-K
f7cr4kdnfzkyrc
23 Jun 22
Annual report of employee stock purchases
5:06pm